QUIDELORTHO CORP (QDEL) Stock Fundamental Analysis
NASDAQ:QDEL - Nasdaq - US2197981051 - Common Stock - Currency: USD
We assign a fundamental rating of 3 out of 10 to QDEL. QDEL was compared to 187 industry peers in the Health Care Equipment & Supplies industry. While QDEL is still in line with the averages on profitability rating, there are concerns on its financial health. QDEL has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
QDEL had positive earnings in the past year.
In the past year QDEL had a positive cash flow from operations.
In multiple years QDEL reported negative net income over the last 5 years.
Each year in the past 5 years QDEL had a positive operating cash flow.
1.2 Ratios
The Return On Assets of QDEL (-5.55%) is better than 66.31% of its industry peers.
QDEL has a better Return On Equity (-11.97%) than 65.78% of its industry peers.
QDEL has a better Return On Invested Capital (1.25%) than 68.45% of its industry peers.
QDEL had an Average Return On Invested Capital over the past 3 years of 4.37%. This is below the industry average of 7.89%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.55% | ||
| ROE | -11.97% | ||
| ROIC | 1.25% |
ROA(3y)-8.62%
ROA(5y)9.28%
ROE(3y)-19.28%
ROE(5y)7.89%
ROIC(3y)4.37%
ROIC(5y)20.45%
1.3 Margins
QDEL's Operating Margin of 3.11% is fine compared to the rest of the industry. QDEL outperforms 68.45% of its industry peers.
In the last couple of years the Operating Margin of QDEL has declined.
QDEL's Gross Margin of 46.94% is in line compared to the rest of the industry. QDEL outperforms 41.18% of its industry peers.
In the last couple of years the Gross Margin of QDEL has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.11% | ||
| PM (TTM) | N/A | ||
| GM | 46.94% |
OM growth 3Y-68.75%
OM growth 5Y-39.02%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.83%
GM growth 5Y-5.07%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so QDEL is destroying value.
QDEL has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, QDEL has more shares outstanding
The debt/assets ratio for QDEL is higher compared to a year ago.
2.2 Solvency
QDEL has an Altman-Z score of 0.88. This is a bad value and indicates that QDEL is not financially healthy and even has some risk of bankruptcy.
QDEL has a Altman-Z score (0.88) which is comparable to the rest of the industry.
QDEL has a Debt/Equity ratio of 0.70. This is a neutral value indicating QDEL is somewhat dependend on debt financing.
QDEL has a worse Debt to Equity ratio (0.70) than 70.59% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.7 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.88 |
ROIC/WACC0.14
WACC8.8%
2.3 Liquidity
QDEL has a Current Ratio of 1.20. This is a normal value and indicates that QDEL is financially healthy and should not expect problems in meeting its short term obligations.
QDEL has a worse Current ratio (1.20) than 83.42% of its industry peers.
QDEL has a Quick Ratio of 1.20. This is a bad value and indicates that QDEL is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of QDEL (0.66) is worse than 91.44% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.2 | ||
| Quick Ratio | 0.66 |
3. Growth
3.1 Past
QDEL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -22.38%.
The Earnings Per Share has been decreasing by -9.03% on average over the past years.
The Revenue has decreased by -3.42% in the past year.
The Revenue has been growing by 39.07% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-22.38%
EPS 3Y-52.97%
EPS 5Y-9.03%
EPS Q2Q%68.18%
Revenue 1Y (TTM)-3.42%
Revenue growth 3Y17.89%
Revenue growth 5Y39.07%
Sales Q2Q%-2.56%
3.2 Future
Based on estimates for the next years, QDEL will show a very strong growth in Earnings Per Share. The EPS will grow by 25.08% on average per year.
QDEL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.31% yearly.
EPS Next Y32.45%
EPS Next 2Y33.47%
EPS Next 3Y32.67%
EPS Next 5Y25.08%
Revenue Next Year-2.19%
Revenue Next 2Y1%
Revenue Next 3Y2.29%
Revenue Next 5Y2.31%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 13.86, which indicates a correct valuation of QDEL.
Based on the Price/Earnings ratio, QDEL is valued cheaply inside the industry as 87.70% of the companies are valued more expensively.
QDEL's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.21.
With a Price/Forward Earnings ratio of 9.04, the valuation of QDEL can be described as very reasonable.
94.65% of the companies in the same industry are more expensive than QDEL, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 21.70. QDEL is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.86 | ||
| Fwd PE | 9.04 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, QDEL is valued cheaper than 94.65% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 8.13 |
4.3 Compensation for Growth
QDEL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
QDEL's earnings are expected to grow with 32.67% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.43
PEG (5Y)N/A
EPS Next 2Y33.47%
EPS Next 3Y32.67%
5. Dividend
5.1 Amount
QDEL does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
29.79
+0.97 (+3.37%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners112.09%
Inst Owner Change3.24%
Ins Owners0.54%
Ins Owner Change1.91%
Market Cap2.01B
Analysts78.67
Price Target51.29 (72.17%)
Short Float %6.06%
Short Ratio2.41
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.18%
Min EPS beat(2)4.59%
Max EPS beat(2)23.78%
EPS beat(4)4
Avg EPS beat(4)65.27%
Min EPS beat(4)4.59%
Max EPS beat(4)162.15%
EPS beat(8)6
Avg EPS beat(8)33.31%
EPS beat(12)9
Avg EPS beat(12)36.06%
EPS beat(16)12
Avg EPS beat(16)30.37%
Revenue beat(2)0
Avg Revenue beat(2)-1.13%
Min Revenue beat(2)-1.51%
Max Revenue beat(2)-0.75%
Revenue beat(4)2
Avg Revenue beat(4)2.64%
Min Revenue beat(4)-1.51%
Max Revenue beat(4)11.02%
Revenue beat(8)5
Avg Revenue beat(8)1.16%
Revenue beat(12)8
Avg Revenue beat(12)1.78%
Revenue beat(16)11
Avg Revenue beat(16)4.61%
PT rev (1m)-5.63%
PT rev (3m)-5.88%
EPS NQ rev (1m)-6.81%
EPS NQ rev (3m)-96.12%
EPS NY rev (1m)1.06%
EPS NY rev (3m)0.35%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.94%
Revenue NY rev (1m)0.14%
Revenue NY rev (3m)-3.01%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.86 | ||
| Fwd PE | 9.04 | ||
| P/S | 0.73 | ||
| P/FCF | N/A | ||
| P/OCF | 13.49 | ||
| P/B | 0.67 | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.13 |
EPS(TTM)2.15
EY7.22%
EPS(NY)3.3
Fwd EY11.06%
FCF(TTM)-0.53
FCFYN/A
OCF(TTM)2.21
OCFY7.41%
SpS40.88
BVpS44.32
TBVpS-5.49
PEG (NY)0.43
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.55% | ||
| ROE | -11.97% | ||
| ROCE | 1.59% | ||
| ROIC | 1.25% | ||
| ROICexc | 1.28% | ||
| ROICexgc | 3.54% | ||
| OM | 3.11% | ||
| PM (TTM) | N/A | ||
| GM | 46.94% | ||
| FCFM | N/A |
ROA(3y)-8.62%
ROA(5y)9.28%
ROE(3y)-19.28%
ROE(5y)7.89%
ROIC(3y)4.37%
ROIC(5y)20.45%
ROICexc(3y)4.54%
ROICexc(5y)30.14%
ROICexgc(3y)17.29%
ROICexgc(5y)56.29%
ROCE(3y)5.53%
ROCE(5y)25.88%
ROICexcg growth 3Y-72.1%
ROICexcg growth 5Y-43.85%
ROICexc growth 3Y-77.1%
ROICexc growth 5Y-42.97%
OM growth 3Y-68.75%
OM growth 5Y-39.02%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.83%
GM growth 5Y-5.07%
F-Score5
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.7 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 3.96 | ||
| Cap/Depr | 41.56% | ||
| Cap/Sales | 6.7% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 28.09% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.2 | ||
| Quick Ratio | 0.66 | ||
| Altman-Z | 0.88 |
F-Score5
WACC8.8%
ROIC/WACC0.14
Cap/Depr(3y)46.16%
Cap/Depr(5y)161.74%
Cap/Sales(3y)6.1%
Cap/Sales(5y)7.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.38%
EPS 3Y-52.97%
EPS 5Y-9.03%
EPS Q2Q%68.18%
EPS Next Y32.45%
EPS Next 2Y33.47%
EPS Next 3Y32.67%
EPS Next 5Y25.08%
Revenue 1Y (TTM)-3.42%
Revenue growth 3Y17.89%
Revenue growth 5Y39.07%
Sales Q2Q%-2.56%
Revenue Next Year-2.19%
Revenue Next 2Y1%
Revenue Next 3Y2.29%
Revenue Next 5Y2.31%
EBIT growth 1Y-34.7%
EBIT growth 3Y-63.16%
EBIT growth 5Y-15.19%
EBIT Next Year933.72%
EBIT Next 3Y133.74%
EBIT Next 5Y88.95%
FCF growth 1Y-109.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-73.95%
OCF growth 3Y-53.13%
OCF growth 5Y-9.2%